Experimental drugs for the inhibition of preterm labor.
Tegan TriggsSailesh KumarMurray D MitchellPublished in: Expert opinion on investigational drugs (2020)
A number of new therapeutic strategies for the prevention of preterm labor are being investigated. These have the potential to improve neurodevelopmental outcomes and survival in babies born preterm, reducing the economic and healthcare costs of caring for the complex needs of these children in the immediate and long term. It is likely that over the next decade there will be a new treatment option that targets the pathological inflammatory processes involved in preterm labor.